Blood patch may keep lungs sealed after cancer treatment

NCT ID NCT06651658

Recruiting now Symptom relief Sponsor: Oxford University Hospitals NHS Trust Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether injecting a patient's own blood into the lung lining (a pleural blood patch) can prevent air leaks after thermal ablation for lung cancer. About 106 adults scheduled for lung ablation will be randomly assigned to receive the blood patch or not. The main goal is to see if the blood patch reduces the need for chest drains, which can cause pain and longer hospital stays.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: pleural blood patch (autologous blood)
What this could lead to: If it works, this simple procedure could reduce the need for chest drains after lung ablation, making recovery faster and safer.
What could go wrong: This is a small, early-stage trial with only 106 participants, so results may not apply to all patients. The blood patch might not reduce air leaks as expected.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

lung cancer lung neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LUNG CANCER LUNG METASTASES

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Oxford University Hospitals NHS Foundation Trust
RECRUITING

Oxford, United Kingdom

Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.